Effectiveness and safety of two different antithymocyte globulins used in induction therapy in kidney transplant recipients: A single-center experience.
Beata StyrcMichał SobolewskiJerzy ChudekAureliusz KolonkoAndrzej WięcekPublished in: Clinical transplantation (2019)
Treatment with Thymoglobulin in kidney transplant recipients resulted in more pronounced lymphopenia and a lower 12-month rate of acute rejection.